The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'The long and winding road for the development of tasquinimod as an oral second-generation quinoline-3-carboxamide antiangiogenic drug for the treatment of prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences